References

Cisplatin: the first metal based anticancer drug

10.1016/j.bioorg.2019.102925 · 2019 · External reference

Platinum-based chemotherapy: trends in organic nanodelivery systems

10.1039/d4nr01483a · 2024 · External reference

Cisplatin in cancer therapy: molecular mechanisms of action

10.1016/j.ejphar.2014.07.025 · 2014 · External reference

Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies

10.1016/j.ejps.2024.106939 · 2024 · External reference

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology

10.1021/cr040704h · 2006 · External reference

Quantification of cisplatin encapsulated in nanomedicine: an overview

10.3390/bios15050293 · 2025 · External reference

Strategies for sustained release of heparin: a review

10.1016/j.carbpol.2022.119793 · 2022 · External reference

Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy

10.1016/j.carbpol.2020.117490 · 2021 · External reference

Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles

10.1021/nn202410f · 2011 · External reference

10.1126/sciadv.adz7615

10.1126/sciadv.adz7615 · External reference

Dumbbell-like Au−Fe3O4 nanoparticles for target-specific platin delivery

10.1021/ja900790v · 2009 · External reference

Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery

10.1016/j.matdes.2019.108187 · 2019 · External reference

Synergic activity against MCF-7 breast cancer cell growth of nanocurcumin-encapsulated and cisplatin-complexed nanogels

10.3390/molecules23123347 · 2018 · External reference

Inhibition of cancer-associated thrombosis with redox-sensitive paclitaxel/heparin-deoxycholic acid nanoparticles

10.1016/j.colcom.2020.100345 · 2021 · External reference

Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system

10.1002/chem.201102926 · 2012 · External reference

Optimization of the poloxamer 407-conjugated gelatin to synthesize pH-sensitive nanocarriers for controlled paclitaxel delivery

10.1007/s10965-024-04248-1 · 2025 · External reference

Poloxamer hydrogels for biomedical applications

10.3390/pharmaceutics11120671 · 2019 · External reference

Self-assembled nanogel of pluronic-conjugated heparin as a versatile drug nanocarrier

10.1007/s13233-011-0214-4 · 2011 · External reference

Heparin-pluronic F127 nanogel with optimal component ratio for drug delivery applications

10.54939/1859-1043.j.mst.88.2023.58-65 · 2023 · External reference

Aquated cisplatin and heparin-pluronic nanocomplexes exhibiting sustainable release of active platinum compound and NCI-H460 lung cancer cell antiproliferation

10.1080/09205063.2016.1154239 · 2016 · External reference

Application of pluronics for enhancing aqueous solubility of lipophilic microtubule destabilizing compounds on the sea urchin embryo model

10.3390/ijms241914695 · 2023 · External reference

Amphiphile-drug interplay: enhanced solubility and drug-tailored self-assembly for delivery applications

2026 · External reference

Novel amphiphilic heparin-pluronic P123 copolymers exhibiting a great potential for cisplatin delivery

10.1007/s10853-018-2569-9 · 2018 · External reference

Unresolved reference

External reference

Development and evaluation of folate-gelatin-poloxamer P407 copolymer nanogels for enhanced co-delivery of paclitaxel and curcumin in breast cancer therapy

2024 · External reference

A study of liposomal formulations to improve the delivery of aquated cisplatin to a multidrug resistant tumor

10.1007/s11095-015-1702-6 · 2015 · External reference

A novel information criterion to elucidate a drug delivery mechanism from poly (acrylamide-co-2-hydroxyethyl methacrylate) reinforced with hydroxyapatite composite

10.1016/j.polymer.2018.10.068 · 2018 · External reference

Biopolymeric nanocapsules exploiting the synergistic effects of methotrexate and curcumin co-delivery via oral or local administration for breast cancer therapy

10.1016/j.xphs.2026.104288 · 2026 · External reference

Gelatinized-polyoxyethylene (100) stearyl ether nanoformulation for enhancing distribution, bioavailability and stability of curcumin in cancer therapy

10.1007/s13233-025-00421-7 · 2025 · External reference

1H and (15)N NMR analyses on heparin, heparan sulfates and related monosaccharides concerning the chemical exchange regime of the N-Sulfo-Glucosamine sulfamate proton

10.3390/ph9030058 · 2016 · External reference

Unresolved reference

2024 · External reference

Structural modification of gelatin-based conjugates for hydrophobic drug delivery: superior efficacy of poloxamer 403 grafting in curcumin and paclitaxel Co-Loading

10.1007/s10876-026-03021-2 · 2026 · External reference

Lipophilic effect of various pluronic-grafted gelatin copolymers on the Quercetin delivery efficiency in these self-assembly nanogels

10.1007/s10965-020-02216-z · 2020 · External reference

Heparin-tagged PLA-PEG copolymer-encapsulated biochanin A-Loaded (Mg/Al) LDH nanoparticles recommended for non-thrombogenic and anti-proliferative stent coating

10.3390/ijms22115433 · 2021 · External reference

Investigation of the properties of chitosan–Pluronic based nanogel drug delivery systems utilizing various pluronic types

10.1002/pen.26923 · 2024 · External reference

pH sensitive and controlled release system based on cellulose nanofibers-poly vinyl alcohol hydrogels for cisplatin delivery

10.1007/s12221-017-6958-5 · 2017 · External reference

Core–shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells

10.1039/c5nr04963f · 2015 · External reference

Size-tunable strategies for a tumor targeted drug delivery system

10.1021/acscentsci.9b01139 · 2020 · External reference

Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems

10.3390/pharmaceutics10020057 · 2018 · External reference

Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles

10.1021/ic301050v · 2012 · External reference

Differentiation of endothelial progenitor cells into endothelial cells by heparin-modified supramolecular pluronic nanogels encapsulating bFGF and complexed with VEGF165 genes

10.1016/j.biomaterials.2014.02.038 · 2014 · External reference

Cisplatin complexes with phosphatidylserine in membranes

10.1021/bi9703047 · 1997 · External reference

Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin

10.1016/j.jinorgbio.2011.05.017 · 2011 · External reference

Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels

10.1039/c6cc08230k · 2017 · External reference

Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery

10.1039/c6ra17213j · 2016 · External reference

Co-Delivery of hesperetin and cisplatin via hyaluronic acid-modified liposome for targeted inhibition of aggression and metastasis of triple-negative breast cancer

10.1021/acsami.3c03233 · 2023 · External reference

Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines

10.2147/ijn.s8595 · 2010 · External reference

Use of half-generation PAMAM dendrimers (G0.5-G3.5) with carboxylate end-groups to improve the DACHPtCl(2) and 5-FU efficacy as anticancer drugs

10.3390/molecules26102924 · 2021 · External reference

Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin

10.1021/bm101080p · 2011 · External reference

A simple equation for the description of solute release. III. Coupling of diffusion and relaxation

10.1016/0378-5173(89)90306-2 · 1989 · External reference

Calculation of predominant drug release mechanism using peppas-sahlin model, Part-I (substitution method): a linear regression approach

10.5958/2231-5713.2016.00033.7 · 2016 · External reference

Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system

10.1016/j.ejps.2017.12.012 · 2018 · External reference

Cholesterol-conjugated PAMAM dendrimers: enhancing stability, drug delivery efficiency, and in vitro anticancer performance

2024 · External reference

Molecular and functional interactions between cisplatin and nicotinamide: a combined computational, spectroscopic, and biological study

10.3390/ijms27114989 · 2026 · External reference

In vitro hemolysis: guidance for the pharmaceutical scientist

10.1002/jps.20627 · 2006 · External reference